Oncologic Drugs Approval in Europe for Solid Tumors: Overview of the Last 6 Years

SIMPLE SUMMARY: We present a systematic overview of EMA-approved oncologic drugs, both as new or extensions of indications, over 6 years, from 2015 to 2020. Our analysis confirms a long-standing trend in drug development for which most of the efforts led to broadening indications of pre-existing mol...

Descripción completa

Detalles Bibliográficos
Autores principales: Falcone, Rosa, Lombardi, Pasquale, Filetti, Marco, Duranti, Simona, Pietragalla, Antonella, Fabi, Alessandra, Lorusso, Domenica, Altamura, Valeria, Paroni Sterbini, Francesco, Scambia, Giovanni, Daniele, Gennaro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870299/
https://www.ncbi.nlm.nih.gov/pubmed/35205637
http://dx.doi.org/10.3390/cancers14040889

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870299/
https://www.ncbi.nlm.nih.gov/pubmed/35205637
http://dx.doi.org/10.3390/cancers14040889

Ejemplares similares